Pharm
Tocolytic
search
Tocolytic
, Tocolysis
See Also
Preterm Labor Management
Indications
Preterm Labor
Contraindications (See specific medications)
Intrauterine Fetal Demise
or lethal fetal anomaly
Nonreassuring Fetal Status
Fetal Bradycardia
<100
Fetal Tachycardia
>180
Severe Preeclampsia
or
Eclampsia
Maternal bleeding with hemodynamic instability
Maternal Systolic
Blood Pressure
<90 mmHg
Maternal cardiopulmonary symptoms (e.g.
Shortness of Breath
,
Chest Pain
)
Chorioamnionitis
Preparations
Preferred Tocolytics
Gene
ral Indications
Stops labor for 24-48 hours
Allows maternal transport and
Corticosteroid
doses
Magnesium Sulfate
Load: 6 grams bolus IV over 20 min (Very high dose!, some protocols use 4 g load)
Maintenance: 2 grams/hour IV infusion (max: 3 g/h)
Must follow protocols for patient safety
Tocolytic and neuroprotective (with decreased risk of
Cerebral Palsy
in deliveries before 32 weeks)
Doyle (2009) Obstet Gynecol 113(6): 1327-33 [PubMed]
Does not prevent preterm birth
Gyetvai (1999) Obstet Gynecol 94:869-77 [PubMed]
Indomethacin
(
Indocin
)
Load: 50-100 mg orally or rectally
Maintenance: 25-50 mg orally every 4-6 hours for up to 48 hours
Avoid use >48 hours (risk of oligohydramnios, premature closure ductus arteriosus)
Not recommended after 32 weeks due to ductus arteriosus constriction
Nifedipine
(
Procardia
)
Load: 30 mg orally
Maintenance: 10-20 mg every 4-6 hours (max: 180 mg/day)
Higher risk of maternal adverse effects when combined with
Magnesium Sulfate
Preparations
Other Tocolytics
Terbutaline
Load: 0.25 mg SQ every 20-30 min for up to 4 doses
Maintenance: 0.25 mg every 3-4 hours until
Uterus
quiet for 24 hours
Effective at temporarily stopping contractions
Results in shortest hospital triage stays
Guinn (1997) Am J Obstet Gynecol 177:814-87 [PubMed]
Oral
Terbutaline
is not effective in
Preterm Labor
Lewis (1996) Am J Obstet Gynecol 175:834-7 [PubMed]
Ritodrine
Not available in the United States as of 2013
Curiously, was the only FDA approved
Preterm Labor
Tocolytic
Not shown to be more effective than
Placebo
(1992) N Engl J Med 327:308-12 [PubMed]
References
(2016) Obstet Gynecol 128(4):e155-64 [PubMed]
Berkman (2003) Am J Obstet Gynecol 188:1648-59 [PubMed]
Haas (2009) Obstet Gynecol 113(3): 585-94 [PubMed]
Sayres (2010) Am Fam Physician 81(4): 477-84 [PubMed]
Type your search phrase here